India's Generic Medicine Industry Faces Data Exclusivity Pressure

India is known as the pharmacy of the world because it makes affordable medicines that help people everywhere.

Some big countries and companies want India to change its rules to make it harder for these affordable medicines to be made.

This is called data exclusivity.

It means that only the first company that makes a medicine can use its data for a long time, making it expensive for others to make cheaper versions.

India has been strong in saying no to this because it wants medicines to be affordable for everyone.

But now, there are signs that India might change its mind.

This is a big deal because if India does this, medicines could become more expensive, and many people who need them might not be able to afford them.

This could make it harder to treat diseases like tuberculosis, HIV-AIDS, and cancer, not just in India but all over the world.